Regulation of GTPase and adenylate cyclase activity by amyloid β-peptide and its fragments in rat brain tissue

Brain Research

Volumn 850, Issue 1-2, 1999, Pages 179-188

  Soomets, Ursel ^a,b   Mahlapuu, Riina ^b   Tehranian, Roya ^a   Jarvet, Jüri ^c   Karelson, Ello ^b   Zilmer, Mihkel ^b   Iverfeldt, Kerstin ^a   Zorko, Matjaz ^a,d   Gräslund, Astrid ^c   Langel, Ülo ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Adenylate cyclase; Alzheimer's disease; Amyloid peptide; GTPase

Indexed keywords

ACETYLCYSTEINE; ADENYLATE CYCLASE; AMYLOID BETA PROTEIN; GLUTATHIONE; GUANOSINE TRIPHOSPHATASE; PEPTIDE FRAGMENT;

ANIMAL TISSUE; ARTICLE; BRAIN; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ADENOSINE DIPHOSPHATE RIBOSE; ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; BRAIN; DIFFUSION; GLUTATHIONE; GTP PHOSPHOHYDROLASES; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; RATS; RATS, WISTAR; VIRULENCE FACTORS, BORDETELLA;

EID: 0032758498     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02142-3     Document Type: Article

References (53)

1. Asano T., Shinohara H., Morshita R., Kato K. Immunochemical and immunohistochemical localization of the G-protein Gi1 in rat central nervous tissues. J. Biochem. 108:1990;988-994.
2. 1 affects the GTPase activity of rat brain cortical membranes. Peptides. 20:1999;177-184.
3. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
4. o heterotrimeric protein within a cell compartment specialized in signal transduction. J. Neurosci. 19:1990;1717-1727.
5. Brown B.L., Ekins R.P., Albano J.D. Saturation assay for cyclic AMP using endogenous binding protein. Adv. Cyclic Nucleotide Res. 2:1972;25-40.
6. Burdick D., Soreghan B., Know M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
7. Butterfield D.A., Hensley K., Harris M., Mattson M.P., Carney J.M. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
8. Butterfield D.A. β-Amyloid-generated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 10:1997;518-526.
9. Cassel D., Selinger Z. Catecholamine stimulated GTPase activity in turkey erythrocyte membranes. Biochim. Biophys. Acta. 452:1976;538-551.
10. Dikalov S.I., Vitek M.P., Maples K.R., Mason R.P. Amyloid β peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalysed oxidation of hydroxylamines to nitroxides. J. Biol. Chem. 274:1999;9392-9399.
11. Ferrari-DiLeo G., Mash D.C., Flynn D.D. Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease. Mol. Chem. Neuropathol. 24:1995;69-91.
12. Furukawa K., Abe Y., Akaike N. Amyloid β protein-induced irreversible current in rat cortical neurones. NeuroReport. 5:1994;2016-2018.
13. Gibbs S.J., Johnson C.S. Jr. A PFG NMR experiment for accurate diffusion and flow studies in the presence of Eddy currents. J. Magn. Reson. 93:1991;395-402.
14. Grady T., Fickova M., Tager H.S., Trivedi D., Hruby J. Stimulation and inhibition of cAMP accumulation by glucagon in canine hepatocytes. J. Biol. Chem. 262:1987;15514-15520.
15. Gridely K.E., Green P.S., Simpkins J.W. A novel, synergistic interaction between 17-beta-estradiol and glutathione in the protection of neurons against beta-amyloid (25-35)-induced toxicity in vitro. Mol. Pharmacol. 54:1998;874-880.
16. Harper J.D., Lansbury P.T. Models of amyloid seeding in Alzheimers's disease and Scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:1997;385-407.
17. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generated by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3270-3274.
18. Higashijima T., Uzu S., Nakajima T., Ross E.M. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J. Biol. Chem. 263:1988;6491-6494.
19. Huang H.M., Gibson G.E. Altered beta-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J. Biol. Chem. 268:1993;14616-14621.
20. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-7616.
21. Iversen L.L., Mortishire-Smith R.J., Pollack S.J., Shearman M.S. The toxicity in vitro of beta-amyloid protein. Biochem. J. 311:1995;1-16.
22. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., Mattson M.P. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6753-6758.
23. Koppal T., Subramaniam R., Drake J., Prasad M.R., Dhillon H., Butterfield D.A. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 786:1998;270-273.
24. Langel Ü., Land T., Bartfai T. Design of chimeric peptide ligands to galanin receptors and substance P receptors. Int. J. Pept. Protein Res. 39:1992;516-522.
25. Longsworth L.G. The mutual diffusion of light and heavy water. J. Phys. Chem. 64:1960;1914-1917.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. Ma H., Weiss C.A. In vitro analysis of G-protein functions. Methods Cell Biol. 49:1951;471-485.
28. Magnaldo I., Pouyssegur J., Paris S. Thrombin exerts a dual effect on stimulated adenylate cyclase in hamster fibroblasts, an inhibition via a GTP-binding protein and potentiation via activation of protein kinase C. Biochem. J. 253:1988;711-719.
29. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
30. Mason R.P., Jacob R.F., Walter M.F., Mason P.E., Avdulov N.A., Chochina S.V., Igbavboa U., Wood W.G. Distribution and fluidizing action of soluble and aggregated amyloid β-peptide in rat synaptic plasma membranes. J. Biol. Chem. 274:1999;18801-18807.
31. Mattson M.P., Begley J.G., Mark R.J., Furukawa K. Aβ25-35 induced rapid lysis of red blood cells: contrast with Aβ1-42 and examination of underlying mechanisms. Brain Res. 771:1997;147-153.
32. F.R. McKenzie, Basic techniques to study G-protein function, in: G. Milligan (Ed.), Signal Transduction. A Practical Approach, Oxford University Press, Oxford, 1992, pp. 31-56.
33. Mousli M., Bueb J.-L., Bronner C., Rouot B., Landry Y. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol. Sci. 11:1990;358-362.
34. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T., Murayama Y., Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature. 362:1993;75-79.
35. Okamoto T., Takeda S., Murayama Y., Ogata E., Nishimoto I. Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J. Biol. Chem. 270:1995;4205-4208.
36. Ross B.M., McLaughlin M., Roberts M., Milligan G., McCulloch J., Knowler J.T. Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease. Brain Res. 622:1993;35-42.
37. Schnecko A., Witte K., Bohl J., Ohm T., Lemmer B. Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected. Brain Res. 644:1994;291-296.
38. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. U. S. A. 92:1995;1989-1993.
39. Sheriff S., Balasubramaniam A. Inhibitory and stimulatory effects of neuropeptide Y (17-36) on rat cardiac adenylate cyclase activity. J. Biol. Chem. 267:1992;4680-4685.
40. Shin Y., Moni R.W., Lueders J.E., Daly J.W. Effects of amphiphilic peptides mastoparan and adenoregulin on receptor binding, G-proteins, phosphoinositide breakdown, cyclic AMP generation, and calcium influx. Cell. Mol. Neurobiol. 14:1994;133-157.
41. Smine A., Xu X., Nishiyama K., Katada T., Gambetti P., Yadav S.P., Wu X., Shi Y.-C., Yasuhara S., Homburger V., Okamoto T. Regulation of brain G-protein Go by Alzheimer's disease gene presenilin-1. J. Biol. Chem. 273:1998;16281-16288.
42. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castano E.M., Frangione B. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nature Medicine. 4:1998;822-826.
43. Stejskal E.O., Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 42:1965;288-292.
44. Terzi E., Holzemann G., Seelig J. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J. Mol. Biol. 252:1995;633-642.
45. Tjernberg L.O., Näslund J., Lindqvist F., Johansson J., Karlström A.R., Thyberg J., Terenius L., Nordstedt C. Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271:1996;8545-8548.
46. Tjernberg L.O., Lilliehöök C., Callaway J.E., Näslund J., Hahne S., Thyberg J., Terenius L., Norstedt C. Controlling amyloid β-peptide fibril formation with protease-stable ligands. J. Biol. Chem. 272:1997;12601-12605.
47. Tjernberg J.O., Callaway J.E., Tjernberg A., Hahne S., Lillehöök C., Terenius L., Thyberg J., Nordstedt C. A molecular model of Alzheimer's amyloid β-peptide fibril formation. J. Biol. Chem. 274:1999;12619-12625.
48. Ulas J., Brunner L.C., Nguyen L., Cotman C.W. Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study. Neuroscience. 52:1993;843-854.
49. Valkna A., Juréus A., Karelson E., Zilmer M., Bartfai T., Langel Ü. Differential regulation of adenylate cyclase activity in rat ventral and dorsal hippocampus by rat galanin. Neurosci. Lett. 187:1995;75-78.
50. Xia W., Zhang J., Kholodenko D., Citron M., Podlisny M.B., Teplow D.B., Haas C., Seubert P., Koo E.H., Selkoe D.J. Enhanced production and oligomerization of the 42-residue amyloid β-protein by chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272:1997;7977-7982.
51. Yatin S.M., Aksenov M., Butterfield D.A. The antioxidant vitamin E modulates amyloid β-peptide induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 24:1999;427-435.
52. Yatin S.M., Yatin M., Aulick T., Ain K.B., Butterfield D.A. Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neurosci. Lett. 263:1999;17-20.
53. Zorko M., Pooga M., Saar K., Rezaei K., Langel Ü. Differential regulation of GTPase activity by mastoparan and galparan. Arch. Biochem. Biophys. 349:1998;321-328.